Is there a role for the no observed adverse effect level in safety pharmacology?
Tomas Mow, Ninette K. Andersen, Nils Dragsted, Anders Blædel Lassen, M.L. Laursen, Alan Bass, Jean‐Pierre Valentin, Carrie Markgraf, Simon Authier, Theodore J. Baird, Siddhartha Bhatt, Martin Traebert, Derek J. Leishman, David Jones, Michael J. Curtis
Topics & Concepts
Safety pharmacologyClinical pharmacologyRubricPharmacologyAdverse effectMedicineContext (archaeology)PsychologyToxicologyDrugBiologyMathematics educationPaleontologyImmunotoxicology and immune responsesAnimal testing and alternativesComputational Drug Discovery Methods